Sept. 20, 2023
Valley fever's mortality rate runs about one death per 1,000 infections, according to Dr. John Galgiani, director of the University of Arizona Valley Fever Center for Excellence. It doesn't need to be so high. To show that a vaccine could be effective protection against Coccidioides, Galgiani and his team started by focusing on an immunization for dogs with the infection. The canine vaccine Galgiani helped to develop has already proved itself. Galgiani believes that if funding allows, a human version of his vaccine could be ready for approval within eight years.